Il Sole 24 ore - pag. 39 February 15, 2011
DiaSorin, a company specializing in in vitro diagnostics, has closed the fourth quarter of 2010 with a net profit of EUR 23 million, an increase of 42.7% compared to 2009. Net sales totaled 109, 3 million (+38.2%). In 2010, revenues net rose 33% to 404.5 million and net profit by 28.8% to 90.2 million. The company expects for 2011 a turnover of between 465 and 475 million with a growth exceeding 15%.
0 comments:
Post a Comment